159 related articles for article (PubMed ID: 32892153)
1. Functional Consequences of Pravastatin Isomerization on OATP1B1-Mediated Transport.
Wagner JB; Ruggiero M; Leeder JS; Hagenbuch B
Drug Metab Dispos; 2020 Nov; 48(11):1192-1198. PubMed ID: 32892153
[TBL] [Abstract][Full Text] [Related]
2. Effects of Uremic Serum Residue on OATP1B1- and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes.
Uchiyama H; Tsujimoto M; Kimura A; Yuki E; Saiki T; Yoshida T; Furukubo T; Izumi S; Yamakawa T; Tachiki H; Minegaki T; Nishiguchi K
Ther Apher Dial; 2019 Apr; 23(2):126-132. PubMed ID: 30318712
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment.
Wu LX; Guo CX; Chen WQ; Yu J; Qu Q; Chen Y; Tan ZR; Wang G; Fan L; Li Q; Zhang W; Zhou HH
Br J Clin Pharmacol; 2012 May; 73(5):750-7. PubMed ID: 22114872
[TBL] [Abstract][Full Text] [Related]
4. Impact of Genetic Variation on Pravastatin Systemic Exposure in Pediatric Hypercholesterolemia.
Wagner JB; Abdel-Rahman S; Gaedigk R; Gaedigk A; Raghuveer G; Staggs VS; Kauffman R; Van Haandel L; Leeder JS
Clin Pharmacol Ther; 2019 Jun; 105(6):1501-1512. PubMed ID: 30549267
[TBL] [Abstract][Full Text] [Related]
5. Explaining Ethnic Variability of Transporter Substrate Pharmacokinetics in Healthy Asian and Caucasian Subjects with Allele Frequencies of OATP1B1 and BCRP: A Mechanistic Modeling Analysis.
Li R; Barton HA
Clin Pharmacokinet; 2018 Apr; 57(4):491-503. PubMed ID: 28653144
[TBL] [Abstract][Full Text] [Related]
6. Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril.
Maeda K; Ieiri I; Yasuda K; Fujino A; Fujiwara H; Otsubo K; Hirano M; Watanabe T; Kitamura Y; Kusuhara H; Sugiyama Y
Clin Pharmacol Ther; 2006 May; 79(5):427-39. PubMed ID: 16678545
[TBL] [Abstract][Full Text] [Related]
7. Mixed effects of OATP1B1, BCRP and NTCP polymorphisms on the population pharmacokinetics of pravastatin in healthy volunteers.
Lu XF; Zhou Y; Bi KS; Chen XH
Xenobiotica; 2016 Sep; 46(9):841-9. PubMed ID: 26744986
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells.
Kameyama Y; Yamashita K; Kobayashi K; Hosokawa M; Chiba K
Pharmacogenet Genomics; 2005 Jul; 15(7):513-22. PubMed ID: 15970799
[TBL] [Abstract][Full Text] [Related]
9. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
10. The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3.
Seithel A; Eberl S; Singer K; Auge D; Heinkele G; Wolf NB; Dörje F; Fromm MF; König J
Drug Metab Dispos; 2007 May; 35(5):779-86. PubMed ID: 17296622
[TBL] [Abstract][Full Text] [Related]
11. Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.
Kivistö KT; Niemi M
Pharm Res; 2007 Feb; 24(2):239-47. PubMed ID: 17177112
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C).
Iwai M; Suzuki H; Ieiri I; Otsubo K; Sugiyama Y
Pharmacogenetics; 2004 Nov; 14(11):749-57. PubMed ID: 15564882
[TBL] [Abstract][Full Text] [Related]
13. Static Model-Based Assessment of OATP1B1-Mediated Drug Interactions with Preincubation-Dependent Inhibitors Based on Inactivation and Recovery Kinetics.
Taguchi T; Masuo Y; Futatsugi A; Kato Y
Drug Metab Dispos; 2020 Sep; 48(9):750-758. PubMed ID: 32616544
[TBL] [Abstract][Full Text] [Related]
14. Construction of HEK293 cells stably expressing wild-type organic anion transporting polypeptide 1B1 (OATP1B1*1a) and variant OATP1B1*1b and OATP1B1*15.
Chen M; Qu BX; Chen XL; Hu HH; Jiang HD; Yu LS; Zhou Q; Zeng S
Pharmazie; 2016 Jun; 71(6):337-9. PubMed ID: 27455553
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.
Nishizato Y; Ieiri I; Suzuki H; Kimura M; Kawabata K; Hirota T; Takane H; Irie S; Kusuhara H; Urasaki Y; Urae A; Higuchi S; Otsubo K; Sugiyama Y
Clin Pharmacol Ther; 2003 Jun; 73(6):554-65. PubMed ID: 12811365
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy.
Furihata T; Satoh N; Ohishi T; Ugajin M; Kameyama Y; Morimoto K; Matsumoto S; Yamashita K; Kobayashi K; Chiba K
Pharmacogenomics J; 2009 Jun; 9(3):185-93. PubMed ID: 19238167
[TBL] [Abstract][Full Text] [Related]
17. The new acyl-CoA cholesterol acyltransferase inhibitor SMP-797 does not interact with statins via OATP1B1 in human cryopreserved hepatocytes and oocytes expressing systems.
Kitamura A; Imai S; Yabuki M; Komuro S
Biopharm Drug Dispos; 2007 Dec; 28(9):517-25. PubMed ID: 17918775
[TBL] [Abstract][Full Text] [Related]
18. Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatin.
Aquilante CL; Kiser JJ; Anderson PL; Christians U; Kosmiski LA; Daily EB; Hoffman KL; Hopley CW; Predhomme JA; Schniedewind B; Sidhom MS
J Clin Pharmacol; 2012 Nov; 52(11):1725-38. PubMed ID: 22174437
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
20. Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.
Farasyn T; Crowe A; Hatley O; Neuhoff S; Alam K; Kanyo J; Lam TT; Ding K; Yue W
J Pharm Sci; 2019 Oct; 108(10):3443-3456. PubMed ID: 31047942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
